Importance Philip Morris International (PMI) is seeking the Food and Drug Administration’s (FDA) authorization to market IQOS as a modified risk tobacco product and making marketing claims of reduced risk and reduced exposure. Such claims may be misunderstood by youth, thereby increasing their risk for tobacco initiation.
British passengers traveling to EU countries will be able to take advantage of duty-free shopping from January 2021, according to HM Treasury.
Though there are earlier examples of tobacco-vapor products, heat-not-burn (HNB) products available from tobacco manufacturers today have found new footing in the fight for market lead over cigarette alternatives, though not without scrutiny.
Heat-not-burn (HNB) products are some of the Next Generation Products (NGP) proposed by the Big Tobacco industry in response to a general concern about tobacco harm-reduction. Such Modified Risk Tobacco Products (MRTPs) consist in heated dried tobacco to produce inhalable vapor, in contrast with cigarettes where the combusted tobacco produces smoke.
A systematic review aiming to calculate the prevalence of smokeless tobacco consumption (STC) by gender and location in Bangladesh, India and Myanmar, found the highest rates of consumption, among men in rural areas.
Because the cost of complying with the regulations is staggeringly high, many manufacturers will not be able to make it over the hurdle, and the e-cigarette market will be left largely to the tobacco giants.
Philip Morris Fortune Tobacco Co. (PMFTC) is opening its first four IQOS stores in Manila, reports The Manilla Standard.
While the heat-not-burn product has been available in the Philippines through several retail outlets since April, the opening of the stores marks a significant step towards achieving the company’s vision of a smoke-free future, according to PMFTC President Denis Gorkun.
Reynolds American Inc. (RAI), has filed its final premarket tobacco product application (PMTA) submissions with the U.S. Food and Drug Administration (FDA) to allow its Vuse and Velo brands to remain on the market in the United States.
To you, Inhaling cigarette somke might just be another cigarette, but to your body, it’s a serious crisis that requires all systems to be put on red alert.
The United States District Court for the District of Maryland has granted FDA’s request for an extension of the premarket review submission deadline for certain tobacco products, which FDA requested due to the COVID-19 pandemic. Applications are now required to be filed by Sept. 9, 2020 for many e-cigarettes, cigars and other deemed tobacco products.
However, in accordance with the U.S. District Court for the District of Columbia ruling issued on Aug. 19, 2020, FDA will not enforce the premarket review requirement against manufacturers of premium cigars that do not submit premarket applications for these products by the Sept. 9, 2020 deadline.
VapeBiz is your international vaping news, articles, policies and reviews website.
Our vision is to promote the communication of global industry, and provide guidance and science popularization to the consumers in this emerging market.
VAPEBIZ uses cookies to ensure you get the best experience on our website. By continuing to browse, you accept and agree to our Cookie Privacy Policy.
Ⓒ 2019-2020 VAPEBIZ.NET All Rights Reserved.
